Generics Cos. Ask Fed. Circ. To Nix Pfizer's Lyrica Patent
A group of generics makers including Teva Pharmaceuticals USA Inc. urged the Federal Circuit on Friday to overturn a lower court's ruling that they infringed a patent for Pfizer Inc.'s blockbuster...To view the full article, register now.
Already a subscriber? Click here to view full article